ATE464305T1 - Bicyclische anilidspirolactame als antagonisten des cgrp-rezeptors - Google Patents
Bicyclische anilidspirolactame als antagonisten des cgrp-rezeptorsInfo
- Publication number
- ATE464305T1 ATE464305T1 AT05795448T AT05795448T ATE464305T1 AT E464305 T1 ATE464305 T1 AT E464305T1 AT 05795448 T AT05795448 T AT 05795448T AT 05795448 T AT05795448 T AT 05795448T AT E464305 T1 ATE464305 T1 AT E464305T1
- Authority
- AT
- Austria
- Prior art keywords
- antagonists
- spirolactames
- cgrp receptor
- cgrp
- anilide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60929204P | 2004-09-13 | 2004-09-13 | |
PCT/US2005/032041 WO2006031610A2 (en) | 2004-09-13 | 2005-09-09 | Bicyclic anilide spirolactam cgrp receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE464305T1 true ATE464305T1 (de) | 2010-04-15 |
Family
ID=36060555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05795448T ATE464305T1 (de) | 2004-09-13 | 2005-09-09 | Bicyclische anilidspirolactame als antagonisten des cgrp-rezeptors |
Country Status (9)
Country | Link |
---|---|
US (1) | US8003792B2 (de) |
EP (1) | EP1797073B1 (de) |
JP (1) | JP2008512481A (de) |
CN (1) | CN101018781A (de) |
AT (1) | ATE464305T1 (de) |
AU (1) | AU2005285109B2 (de) |
CA (1) | CA2579847A1 (de) |
DE (1) | DE602005020656D1 (de) |
WO (1) | WO2006031610A2 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008512459A (ja) | 2004-09-09 | 2008-04-24 | メルク エンド カムパニー インコーポレーテッド | アリールスピロラクタムcgrp受容体拮抗薬 |
US7390798B2 (en) * | 2004-09-13 | 2008-06-24 | Merck & Co., Inc. | Carboxamide spirolactam CGRP receptor antagonists |
AU2005285083B2 (en) | 2004-09-13 | 2011-03-10 | Merck Sharp & Dohme Corp. | Tricyclic anilide spirohydantoin CGRP receptor antagonists |
US7875627B2 (en) * | 2004-12-07 | 2011-01-25 | Abbott Laboratories | Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof |
CN101282953A (zh) * | 2005-08-08 | 2008-10-08 | 阿斯利康(瑞典)有限公司 | 治疗剂 |
DE602006019304D1 (de) | 2005-11-18 | 2011-02-10 | Merck Sharp & Dohme | Spirohydantoin-aryl-cgrp-rezeptorantagonisten |
AU2006316644B2 (en) | 2005-11-18 | 2011-11-10 | Merck Sharp & Dohme Corp. | Spirohydantoin tricyclic CGRP receptor antagonists |
AU2006316627A1 (en) * | 2005-11-18 | 2007-05-31 | Merck Sharp & Dohme Corp. | Spirolactam aryl CGRP receptor antagonists |
US8071772B2 (en) | 2005-11-18 | 2011-12-06 | Merck Sharp & Dohme Corp. | Spirolactam bicyclic CGRP receptor antagonists |
JP2009515973A (ja) * | 2005-11-18 | 2009-04-16 | メルク エンド カムパニー インコーポレーテッド | スピロラクタム三環式cgrp受容体アンタゴニスト |
CN101443323A (zh) * | 2006-05-09 | 2009-05-27 | 默克公司 | 取代的螺环cgrp受体拮抗剂 |
AU2007275577A1 (en) * | 2006-07-21 | 2008-01-24 | Vertex Pharmaceuticals Incorporated | CGRP receptor antagonists |
US7951795B2 (en) * | 2006-12-08 | 2011-05-31 | Merck Sharp & Dohme Corp. | Constrained spirocyclic compounds as CGRP receptor antagonists |
EP1958947A1 (de) * | 2007-02-15 | 2008-08-20 | Ranbaxy Laboratories Limited | Inhibitoren für Phosphodiesterase Typ 4 |
WO2008112159A2 (en) | 2007-03-12 | 2008-09-18 | Merck & Co., Inc. | Monocyclic anilide spirolactam cgrp receptor antagonists |
EP2146715A4 (de) * | 2007-04-11 | 2011-08-31 | Merck Sharp & Dohme | Cgr-rezeptorantagonisten mit tertiären amid-, sulfonamid-, carbamat- und harnstoffendgruppen |
AU2008241500A1 (en) * | 2007-04-16 | 2008-10-30 | Merck Sharp & Dohme Corp. | Aryl heterocyclic CGRP receptor antagonists |
WO2008130512A1 (en) * | 2007-04-16 | 2008-10-30 | Merck & Co., Inc. | Bicyclic anilide heterocyclic cgrp receptor antagonists |
WO2008153849A1 (en) * | 2007-06-05 | 2008-12-18 | Merck & Co., Inc. | Carboxamide heterocyclic cgrp receptor antagonists |
CA2711367A1 (en) * | 2008-02-19 | 2009-08-27 | Merck Sharp & Dohme Corp. | Imidazobenzazepine cgrp receptor antagonists |
WO2010027927A1 (en) * | 2008-09-08 | 2010-03-11 | Merck Sharp & Dohme Corp. | Monocyclic amide cgrp receptor antagonists |
WO2010033421A1 (en) * | 2008-09-18 | 2010-03-25 | Merck Sharp & Dohme Corp. | Bicyclic dihydroimidazolone cgrp receptor antagonists |
TWI522355B (zh) | 2010-11-12 | 2016-02-21 | 默沙東藥廠 | 六氫吡啶酮甲醯胺氮雜茚滿cgrp受體拮抗劑 |
CA2870019C (en) | 2012-04-26 | 2020-08-18 | Francis Xavier Tavares | Synthesis of lactams |
AU2014212501A1 (en) * | 2013-01-29 | 2015-07-30 | Aptinyx, Inc. | Spiro-lactam NMDA receptor modulators and uses thereof |
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
CA2937315A1 (en) | 2014-02-05 | 2015-08-13 | Merck Sharp & Dohme Corp. | Tablet formulation for cgrp-active compounds |
TW201607923A (zh) | 2014-07-15 | 2016-03-01 | 歌林達有限公司 | 被取代之氮螺環(4.5)癸烷衍生物 |
JP6509321B2 (ja) | 2014-07-15 | 2019-05-08 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 置換アザスピロ(4.5)デカン誘導体 |
EP3414247B1 (de) * | 2016-02-08 | 2021-04-21 | F. Hoffmann-La Roche AG | Spiroindolinone als ddr1-hemmer |
NZ749275A (en) | 2016-07-01 | 2023-06-30 | G1 Therapeutics Inc | Synthesis of n-(heteroaryl)-pyrrolo[2,3-d]pyrimidin-2-amines |
EP3366286A1 (de) | 2017-02-22 | 2018-08-29 | Johannes Keller | Verbindungen zur behandlung von sepsis |
RU2019142591A (ru) | 2017-06-29 | 2021-07-29 | Г1 Терапьютикс, Инк. | Морфологические формы g1t38 и способы их получения |
SG11202101807SA (en) | 2018-08-24 | 2021-03-30 | G1 Therapeutics Inc | Improved synthesis of 1,4-diazaspiro[5.5]undecan-3-one |
US11717515B2 (en) | 2020-12-22 | 2023-08-08 | Allergan Pharmaceuticals International Limited | Treatment of migraine |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1209361C (zh) * | 2000-05-03 | 2005-07-06 | 霍夫曼-拉罗奇有限公司 | 含乙内酰脲的葡糖激酶激活剂 |
JP4673294B2 (ja) | 2003-03-14 | 2011-04-20 | メルク・シャープ・エンド・ドーム・コーポレイション | 二環式アニリドスピロヒダントインcgrp受容体拮抗物質 |
EP1606286B1 (de) | 2003-03-14 | 2011-05-11 | Merck Sharp & Dohme Corp. | Benzodiazepinspirohydantoine als cgrp-rezeptorantagonisten |
AU2004222328B2 (en) | 2003-03-14 | 2009-10-08 | Merck Sharp & Dohme Corp. | Aryl spirohydantoin CGRP receptor antagonists |
AU2004221891B2 (en) | 2003-03-14 | 2009-11-19 | Merck Sharp & Dohme Corp. | Monocyclic anilide spirohydantoin CGRP receptor antagonists |
AU2005282466B2 (en) * | 2004-09-08 | 2011-03-10 | Merck Sharp & Dohme Corp. | Monocyclic anilide spirolactam CGRP receptor antagonists |
US7696192B2 (en) * | 2004-09-09 | 2010-04-13 | Merck Sharp & Dohme Corp. | Tricyclic anilide spirolactam CGRP receptor antagonists |
US7390798B2 (en) * | 2004-09-13 | 2008-06-24 | Merck & Co., Inc. | Carboxamide spirolactam CGRP receptor antagonists |
CN101443323A (zh) * | 2006-05-09 | 2009-05-27 | 默克公司 | 取代的螺环cgrp受体拮抗剂 |
-
2005
- 2005-09-09 EP EP05795448A patent/EP1797073B1/de active Active
- 2005-09-09 AT AT05795448T patent/ATE464305T1/de not_active IP Right Cessation
- 2005-09-09 US US11/662,703 patent/US8003792B2/en active Active
- 2005-09-09 DE DE602005020656T patent/DE602005020656D1/de active Active
- 2005-09-09 CN CNA2005800306054A patent/CN101018781A/zh active Pending
- 2005-09-09 JP JP2007531342A patent/JP2008512481A/ja active Pending
- 2005-09-09 WO PCT/US2005/032041 patent/WO2006031610A2/en active Application Filing
- 2005-09-09 AU AU2005285109A patent/AU2005285109B2/en not_active Ceased
- 2005-09-09 CA CA002579847A patent/CA2579847A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US8003792B2 (en) | 2011-08-23 |
WO2006031610A3 (en) | 2006-08-31 |
JP2008512481A (ja) | 2008-04-24 |
AU2005285109B2 (en) | 2011-03-03 |
DE602005020656D1 (de) | 2010-05-27 |
EP1797073A2 (de) | 2007-06-20 |
EP1797073A4 (de) | 2009-09-02 |
WO2006031610A2 (en) | 2006-03-23 |
EP1797073B1 (de) | 2010-04-14 |
CN101018781A (zh) | 2007-08-15 |
US20080096878A1 (en) | 2008-04-24 |
CA2579847A1 (en) | 2006-03-23 |
AU2005285109A1 (en) | 2006-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE464305T1 (de) | Bicyclische anilidspirolactame als antagonisten des cgrp-rezeptors | |
ATE537153T1 (de) | Arylspirolactamverbindungen als antagonisten des cgrp-rezeptors | |
ATE463245T1 (de) | Tricyclische anilid-spirohydantoin-cgrp- rezeptorantagonisten | |
ATE394400T1 (de) | Bicyclische anilidspirohydantoine als cgrp- rezeptorantagonisten | |
WO2006029153A3 (en) | Monocyclic anilide spirolactam cgrp receptor antagonists | |
ATE518852T1 (de) | Tricyclische anilid-spirohydantoin-cgrp- rezeptorantagonisten | |
WO2006031606A3 (en) | Carboxamide spirolactam cgrp receptor antagonists | |
ATE411323T1 (de) | Cgrp-rezeptorantagonisten | |
ATE535514T1 (de) | Carboxamid-spirohydantoin-cgrp-rezeptor- antagonisten | |
ATE509019T1 (de) | Benzodiazepinspirohydantoine als cgrp- rezeptorantagonisten | |
ATE537170T1 (de) | Cgrp-rezeptorantagonisten | |
TW200505903A (en) | CGRP receptor antagonists | |
ATE556060T1 (de) | Monocyclische anilidspirohydantoine als cgrp- rezeptorantagonisten | |
ATE516803T1 (de) | Aryl-spirohydantoin-cgrp-rezeptor-antagonisten | |
ATE503755T1 (de) | Cgrp-rezeptorantagonisten | |
WO2008112159A3 (en) | Monocyclic anilide spirolactam cgrp receptor antagonists | |
ATE466860T1 (de) | Cgrp-rezeptorantagonisten | |
ATE507880T1 (de) | Cgrp-rezeptorantagonisten | |
ATE466853T1 (de) | Cgrp-rezeptorantagonisten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |